QUATTROVAC

This brand name is authorized in Japan.

Active ingredients

The drug QUATTROVAC contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Pertussis toxin
	Read more about Pertussis toxoid
`2`	Pertussis filamentous hemagglutinin UNII `8C367IY4EY` - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Pertussis filamentous hemagglutinin
`3`	Diphtheria toxoid UNII `3U7E3O07S8` - CORYNEBACTERIUM DIPHTHERIAE
	Read more about Diphtheria toxoid
`4`	Tetanus toxoid UNII `K3W1N8YP13` - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Tetanus toxoid
`5`	Inactivated poliovirus type 1 (Sabin strain) UNII `0LVY784C09` - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 1
`6`	Inactivated poliovirus type 2 (Sabin strain) UNII `23JE9KDF4R` - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 2
`7`	Inactivated poliovirus type 3 (Sabin strain) UNII `459ROM8M9M` - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 3

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
JP	医薬品医療機器総合機構	636140DG2028

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.